TACROLIMUS capsules (Adoport®, Prograf® or Modigraf®)

Clinical Indication

Immunosuppression post renal transplant - prescribe by brand name only as different brands are not interchangeable

Comments

Exception agreed to red status: Full shared care to allow GPs to continue supplying to historical patients still on shared care where appropriate for patient and the GP agrees.
Full SCA

Local guidance

Reviewed by LMSG Feb 2018

Date of classification

February 2018

Review date

February 2021

Amber FULL SCA

Drugs which would initially be prescribed by a hospital specialist and then by a GP where full agreement to share the care of each specific patient has been reached under a LMSG Shared Care Agreement (SCA). Specific patient monitoring or intervention required.